A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Albendazole (ALBENZA)

Anthelmintic class · 6 generic manufacturers · 6 ANDAs filed at FDA.

First FDA approval1996-06-11
Generic availableYes · 6 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$7.8M in CY2024 Part D spend19K claims · 14K beneficiaries · 329 plans surveyed

Lowest NADAC
$4.40/unit
5 NDCs benchmarked, lowest of all strengths.
Average NADAC
$4.40
Across all dosage forms in distribution.
Highest NADAC
$4.40
Range is tight.
Plans with PA
52 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Albendazole used for?

Albendazole is a Anthelmintic medication tracked in Medicare Part D.

Is there a generic for Albendazole?

Yes. 6 ANDAs filed at FDA, 6 generic manufacturers currently shipping.

How much does my plan pay for Albendazole?

Across 329 Part D plans, Albendazole averages $4.40/unit (NADAC). Lowest available: $4.40/unit. Highest in distribution: $4.40/unit.

Is Albendazole on the FDA shortage list?

No. Albendazole is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anthelmintic3 alternatives in D1
01
Mebendazole
Brand: VERMOX
Lowest NADAC
1Generic mfrs
$10.1MCY24 Part D spend
Compare →
02
Praziquantel
Brand: Biltricide
$54.65Lowest NADAC
1Generic mfrs
$1.8MCY24 Part D spend
Compare →
03
Triclabendazole
Brand: EGATEN
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (6 approvals on file) · NADAC unit costs: CMS NADAC weekly file (5 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.